中文 | English
Return
Total: 11 , 1/2
Show Home Prev Next End page: GO
MeSH:(Glaucoma, Neovascular/*etiology)

2.Pericardium Plug in the Repair of the Corneoscleral Fistula After Ahmed Glaucoma Valve Explantation.

Chungkwon YOO ; Sung Wook KWON ; Yong Yeon KIM

Korean Journal of Ophthalmology 2008;22(4):268-271

3.Neovascular Glaucoma Due to Branch Retinal Vein Occlusion Combined with Branch Retinal Artery Occlusion.

Tae Su AN ; Soon Il KWON

Korean Journal of Ophthalmology 2013;27(1):64-67

4.Opacification of the Optic of an Akreos Adapt Intraocular Lens.

Chong Eun LEE ; Yu Cheol KIM ; Sung Dong CHANG

Korean Journal of Ophthalmology 2010;24(6):371-373

5.A Case of Cholesterosis Bulbi with Secondary Glaucoma Treated by Vitrectomy and Intravitreal Bevacizumab.

Jongseok PARK ; Hoyoung LEE ; Young Kook KIM ; Jeong Don CHAE ; Hyun Joo LEE

Korean Journal of Ophthalmology 2011;25(5):362-365

6.Neovascular Glaucoma Following Stereotactic Radiosurgery for an Optic Nerve Glioma: A Case Report.

Sohee JEON ; Na Young LEE ; Chan Kee PARK

Korean Journal of Ophthalmology 2010;24(4):252-255

7.Intravitreal Bevacizumab for the Treatment of Neovascular Glaucoma Associated With Central Retinal Artery Occlusion.

Min SAGONG ; Jinseon KIM ; Woohyok CHANG

Korean Journal of Ophthalmology 2009;23(3):215-218

8.Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series.

Jin Young CHOI ; Jaewan CHOI ; Yeon Deok KIM

Korean Journal of Ophthalmology 2010;24(1):47-52

9.Progression of Impending Central Retinal Vein Occlusion to the Ischemic Variant Following Intravitreal Bevacizumab.

Na Rae KIM ; Hee Seung CHIN

Korean Journal of Ophthalmology 2010;24(3):179-181

10.Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome.

Sang Joon LEE ; Jung Joo LEE ; Soo Young KIM ; Shin Dong KIM

Korean Journal of Ophthalmology 2009;23(2):132-134

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 11 , 1/2 Show Home Prev Next End page: GO